Get the Stockscreener App
2.535
3.79%
-0.105
Why is Erasca Inc (ERAS) Stock down?
We've noticed a 5.38% decline in Erasca Inc (ERAS) stock during the 2024-11-20 trading session. While this could be attributed to normal volatility or various internal and external factors, please be aware that we are actively monitoring the situation, and we'll provide timely updates as soon as possible!
28 Nov, 2023:
Shares of Erasca Inc (ERAS) dropped by 11.38% from $2.24 to $1.99 in the trading on Tuesday, November 28, 2023. The reason why ERAS is down today is due to the company's program updates, particularly regarding its SEACRAFT-2 Phase 3 trial for Naporafenib Plus Trametinib and its THUNDERBBOLT-1 Phase 1 trial for ERAS-801. Investors may have been concerned about the trial details, including the patient population and comparator arm in SEACRAFT-2, as well as the need for additional data for ERAS-801. Additionally, the company's decision to deprioritize certain programs and focus on more promising initiatives could have contributed to the stock's decline.
0.42%
0.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):